TrialDaily: Pipeline Briefs

The drug pipeline, briefed daily. Every weekday, TrialDaily reads the day's clinical-trial registrations and FDA activity — hundreds of records — and briefs the moves that actually matter. Built for biotech investors, pharma and biotech professionals, clinicians, and anyone tracking a therapy area closely. What you get: - One curated briefing every weekday, led by the day's most consequential move - Phase 2/3 trial launches, results postings, FDA approvals, and drug recalls - Plain-language briefs: what changed, the particulars, why it matters, what to watch - The verifiable facts alongside every brief — sponsor, phase, enrollment, endpoints, application number - A direct link to the primary record on ClinicalTrials.gov or FDA.gov, on every single item - Search across every trial, approval and recall we've tracked - Full archive of past briefings - Read in English or 简体中文 Where the data comes from: ClinicalTrials.gov, the FDA's openFDA Drugs@FDA and enforcement databases, and the FDA newsroom. All public, all authoritative. Summaries are AI-generated from those records and always link back to the original. Free readers get the day's lead story. Premium unlocks the full daily briefing, the complete archive, and search. 7-day free trial. $6.99/month or $59.99/year. Cancel anytime. Important: TrialDaily is a news product. It reports on registered trials and published regulatory actions. It is not medical advice and does not provide diagnosis or treatment recommendations. Talk to a qualified clinician about your care. Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/